Jyh-Fei Liao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jyh-Fei Liao has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Lili Yu
Department of Basic Medicine Jiangsu Vocational College of Medicine Yancheng China
2 shared publications C. Chen
Department & Institute of Pharmacology, National Yang-Ming Medical College, Taipei, Taiwan
1 shared publicationChang-Ming Chern
Neurovascular Disease, Neurological Institute, Taipei Veterans General Hospital & School of Medicine, National Yang-Ming University, Taipei, Taiwan
1 shared publicationChieh-Fu Chen
National Research Institute of Chinese Medicine, Taipei, Taiwan
1 shared publication- Hsuan-Miao Liu
Graduate Institute of Traditional Chinese Medicine, School of Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
1 shared publication - Kuo-Tong Liou
National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei City 112026, Taiwan
1 shared publication
Latest Publications
- 1 October 2010
- Published by Elsevier in Phytomedicine
- Vol. 17 (12) , 963-973
Preventive effect of silymarin in cerebral ischemia–reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation
- 1 October 2010
- Published by Elsevier in Phytomedicine
- Vol. 17 (12) , 963-973
Preventive effect of silymarin in cerebral ischemia–reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation
- 1 October 1997
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 63 (05) , 471-472
6-Methoxy-N-methyl-1,2,3,4-tetrahydro-β-carboline from Evodiae Fructus
A receptor binding assay directed separation has led to the identification of a minor alkaloid 6-methoxy-N-methyl-1,2, 3,4-tetrahydro-β-carboline (1) from the Chinese herbal drug Evodiae Fructus [EF, the dried, unripe fruit of Evodia rutaecarpa Look. f. et Thomas (Rutaceae)]. The structure of compound 1 was elucidated by means of spectroscopic methods and a comparison with synthetic materials. Compound 1 interacted with 5-HT1A and 5-HT2 receptors with a moderate Ki value of 78 and 1.2 µM, respectively. Compound 1 is found in EF and the genus Evodiae for the first time.
- 1 October 1997
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 63 (05) , 471-472
6-Methoxy-N-methyl-1,2,3,4-tetrahydro-β-carboline from Evodiae Fructus
A receptor binding assay directed separation has led to the identification of a minor alkaloid 6-methoxy-N-methyl-1,2, 3,4-tetrahydro-β-carboline (1) from the Chinese herbal drug Evodiae Fructus [EF, the dried, unripe fruit of Evodia rutaecarpa Look. f. et Thomas (Rutaceae)]. The structure of compound 1 was elucidated by means of spectroscopic methods and a comparison with synthetic materials. Compound 1 interacted with 5-HT1A and 5-HT2 receptors with a moderate Ki value of 78 and 1.2 µM, respectively. Compound 1 is found in EF and the genus Evodiae for the first time.
- 1 August 1994
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 60 (04) , 308-312
Effect of the Crude Extract of Evodiae Fructus on the Intestinal Transit in Mice
One of the uses of Evodiae Fructus (EF, the dried, unripe fruit of Evodia rutaecarpa) in Chinese medicine is recommended in diarrhea, but its underlying mechanism has not yet been studied. The present study examined the effect of an aqueous extract of EF on the intestinal transit in mice by the charcoal meal method. Intraperitoneal administration {i.p.) of EF (1.9-30 µg/kg) significantly inhibited the intestinal transit in a dose- and time-dependent manner. This inhibitory effect of EF was not attenuated by the i.p. pretreatment with an α2-, α1, or β-adrenoceptor antagonist, i.e. yohimbine (l0 mg/kg), prazosin (2 mg/kg), or propranolol (6 mg/kg), respectively. In the isolated mouse duodenum, jejunum, and ileum preparations, EF (10-50 mg/ml) concentration-dependently abolished 10 µM carbachol-induced contraction with an IC50 of 9.9, 11.7, and 16.3 mg/ml, respectively. This inhibitory effect was not competitive. Receptor binding assay snowed that EF (1-50 mg/ml) significantly competed with [3 H]-N-methylscopolamine for specific binding to muscarinic receptors on the duodenum, jejunum, and ileum membrane preparations with a Ki value of 7.1, 8.4, and 14.4 mg/ml, respectively. Therefore, the above results suggested that the inhibitory effect of EF on intestinal transit was probably via an action directly on the muscarinic receptors but not on the α2, α1-, and β-adrenoceptors in the small intestine.
- 1 August 1994
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 60 (04) , 308-312
Effect of the Crude Extract of Evodiae Fructus on the Intestinal Transit in Mice
One of the uses of Evodiae Fructus (EF, the dried, unripe fruit of Evodia rutaecarpa) in Chinese medicine is recommended in diarrhea, but its underlying mechanism has not yet been studied. The present study examined the effect of an aqueous extract of EF on the intestinal transit in mice by the charcoal meal method. Intraperitoneal administration {i.p.) of EF (1.9-30 µg/kg) significantly inhibited the intestinal transit in a dose- and time-dependent manner. This inhibitory effect of EF was not attenuated by the i.p. pretreatment with an α2-, α1, or β-adrenoceptor antagonist, i.e. yohimbine (l0 mg/kg), prazosin (2 mg/kg), or propranolol (6 mg/kg), respectively. In the isolated mouse duodenum, jejunum, and ileum preparations, EF (10-50 mg/ml) concentration-dependently abolished 10 µM carbachol-induced contraction with an IC50 of 9.9, 11.7, and 16.3 mg/ml, respectively. This inhibitory effect was not competitive. Receptor binding assay snowed that EF (1-50 mg/ml) significantly competed with [3 H]-N-methylscopolamine for specific binding to muscarinic receptors on the duodenum, jejunum, and ileum membrane preparations with a Ki value of 7.1, 8.4, and 14.4 mg/ml, respectively. Therefore, the above results suggested that the inhibitory effect of EF on intestinal transit was probably via an action directly on the muscarinic receptors but not on the α2, α1-, and β-adrenoceptors in the small intestine.